Results 11 to 20 of about 345,077 (288)

Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis.

open access: yesNew England Journal of Medicine, 2007
D. Black   +20 more
semanticscholar   +3 more sources

Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis.

open access: yesNew England Journal of Medicine, 2001
R. Neer   +11 more
semanticscholar   +3 more sources

Postmenopausal osteoporosis coexisting with sarcopenia: the role and mechanisms of estrogen.

open access: yesJournal of Endocrinology, 2023
Estrogens (estradiol, estriol, and estrone) are important hormones that directly and indirectly regulate the metabolism and function of bone and skeletal muscle via estrogen receptors.
Lingyun Lu, L. Tian
semanticscholar   +1 more source

Asia–pacific consensus on osteoporotic fracture prevention in postmenopausal women with low bone mass or osteoporosis but no fragility fractures

open access: yesJournal of the Formosan Medical Association, 2023
Postmenopausal women are at significant risk for osteoporotic fractures due to their rapid bone loss. Half of all postmenopausal women will get an osteoporosis-related fracture over their lifetime, with 25% developing a spine deformity and 15% developing
Chun-Feng Huang   +25 more
doaj   +1 more source

Identification of miR-194-5p as a potential biomarker for postmenopausal osteoporosis [PDF]

open access: yesPeerJ, 2015
The incidence of osteoporosis is high in postmenopausal women due to altered estrogen levels and continuous calcium loss that occurs with aging. Recent studies have shown that microRNAs (miRNAs) are involved in the development of osteoporosis.
Jia Meng   +8 more
doaj   +2 more sources

Stress-Related Amygdala Metabolic Activity Is Associated With Low Bone Mineral Density in Postmenopausal Women: A Pilot 18F-FDG PET/CT Study

open access: yesFrontiers in Endocrinology, 2021
BackgroundPsychological stress is associated with postmenopausal osteoporosis. However, the underlying mechanism of stress-related brain neural activity with osteoporosis is not fully elucidated.
Kisoo Pahk   +3 more
doaj   +1 more source

T-Cell Mediated Inflammation in Postmenopausal Osteoporosis

open access: yesFrontiers in Immunology, 2021
Osteoporosis is the most prevalent metabolic bone disease that affects half the women in the sixth and seventh decade of life. Osteoporosis is characterized by uncoupled bone resorption that leads to low bone mass, compromised microarchitecture and ...
Di Wu   +5 more
semanticscholar   +1 more source

Long-Term Treatment of Postmenopausal Osteoporosis

open access: yesEndocrinology and Metabolism, 2021
Osteoporosis is an incurable chronic condition, like heart disease, diabetes, or hypertension. A large gap currently exists in the primary prevention of fractures, and studies show that an estimated 80% to 90% of adults do not receive appropriate ...
Jacques P. Brown
semanticscholar   +1 more source

Association of a history of gestational diabetes mellitus with osteoporosis, bone mineral density, and trabecular bone score in postmenopausal women

open access: yesDiabetology & Metabolic Syndrome, 2023
Background Studies on the association of gestational diabetes mellitus (GDM) with osteoporosis, and bone mineral density (BMD) have been inconsistent.
Boqi Lu, Liping Zhang
doaj   +1 more source

Effect of drugs on bone mineral density in postmenopausal osteoporosis: a Bayesian network meta-analysis

open access: yesJournal of Orthopaedic Surgery and Research, 2021
Background Osteoporosis affects mostly postmenopausal women, leading to deterioration of the microarchitectural bone structure and low bone mass, with an increased fracture risk with associated disability, morbidity and mortality.
Filippo Migliorini   +5 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy